Alizyme PLC (AZM.L) The UK Based Speciality Biopharmaceutical Development Company, Today Announces That It Proposes To Raise £32.8 Million 
10/19/2005 5:11:08 PM

21 April 2005, Cambridge, UK: Alizyme plc (London Stock Exchange: AZM), the UK based speciality biopharmaceutical development company, today announces that it proposes to raise £32.8 million (approximately £30.5 million net of expenses) by means of a Placing and Open Offer and a further private placement in the US to QFinance, Inc. ("Quintiles") (together "the Offers") comprising an aggregate of 32,808,419 New Ordinary Shares at a price of 100 pence per New Ordinary Share.